Immune organoid for cancer immunotherapy
Cancer immunotherapy, which harnesses the patient's own immune system to target malignant cells, has shown remarkable promise in reducing tumor burden and extending survival. However, the complex tumor microenvironment (TME) limits therapeutic benefits to a subset of patients, making it challen...
Saved in:
| Main Authors: | Xiao-He Wang, Wu-Yin Wang, Zhi-Jun Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383525002989 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient‐Derived Bladder Cancer Organoids as a Valuable Tool for Understanding Tumor Biology and Developing Personalized Treatment
by: Hongda Zhao, et al.
Published: (2025-04-01) -
A novel organoid model retaining the glioma microenvironment for personalized drug screening and therapeutic evaluation
by: Chengjun Zheng, et al.
Published: (2025-11-01) -
Organoid Models in Cancer Immunotherapy: Bioengineering Approach for Personalized Treatment
by: Syarifah Tiara Noorintan, et al.
Published: (2024-09-01) -
Reproducible extracellular matrices for tumor organoid culture: challenges and opportunities
by: Kan Li, et al.
Published: (2025-05-01) -
Patient-derived gastric cancer organoids model heterogeneity and stroma-mediated chemoresistance in poorly cohesive carcinoma
by: Yi Yin, et al.
Published: (2025-06-01)